ArticleJournal of the American Society for Mass Spectrometry2015
Cationic Xylene Tag for Increasing Sensitivity in Mass Spectrometry.
Article in Journal of the American Society for Mass Spectrometry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 18 citations in OpenAlex.
- Mass Spectrometry-Based Method to Measure Aflatoxin BChemical research in toxicology · 2024Article
- Qualitative and Quantitative Analytical Techniques of Nucleic Acid Modification Based on Mass Spectrometry for Biomarker Discovery.International journal of molecular sciences · 2024Review
- Enhanced LC-ESI-MS/MS Sensitivity by Cationic Derivatization of Organophosphorus Acids.Molecules (Basel, Switzerland) · 2023Article
- A high-specificity aniline-based mass tag for aldehyde detection.Rapid communications in mass spectrometry : RCM · 2022Article
- DNA Adductomics by mass tag prelabeling.Rapid communications in mass spectrometry : RCM · 2021Article
- Integrating exhaled breath diagnostics by disease-sniffing dogs with instrumental laboratory analysis.Journal of breath research · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
N-(2-(Bromomethyl)benzyl)-N,N-diethylethanaminium bromide, that we designate as CAX-B (cationic xylyl-bromide), is presented as a derivatization reagent for increasing sensitivity in mass spectrometry. Because of its aryl bromomethyl moiety, CAX-B readily labels compounds having an active hydrogen. In part, a CAX-tagged analyte (CAX-analyte) can be very sensitive especially in a tandem mass spectrometer (both ESI and MALDI). This is because of facile formation of an analyte-characteristic first product ion (as a xylyl-based cation) from favorable loss of triethylamine as a neutral from the precursor ion. This loss is enhanced both by resonance stabilization of the xylyl cation, and by anchimeric assistance from the ortho hetero atom of the attached analyte. High intensity of a first product ion opens up the opportunity for a CAX-analyte to be additionally sensitive when it is prone to a secondary neutral loss from the analyte part. For example, we have derivatized and detected 160 amol of thymidine by CAX-tagging/LC-MALDI-TOF/TOF-MS in this way, where the two neutral losses are triethylamine and deoxyribose. Other analytes detected at the amol level as CAX derivatives (as diluted standards) include estradiol and some nucleobases. The tendency for analytes with multiple active hydrogens to label just once with CAX (an advantage) is illustrated by the conversion of bisphenol A to a single product even when excess CAX-B is present. A family of analogous reagents with a variety of reactivity groups is anticipated as a consequence of replacing the bromine atom of CAX-B with various functional groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.